Epidemiology and Treatment of Male Androgenetic Alopecia
January 2022
in “
Journal of Healthcare Sciences
”
TLDR Male Androgenetic Alopecia, a common hair loss in men, can be slowed and partially restored with treatments like minoxidil and finasteride, or hair transplantation. Serenoa repens may be an alternative treatment. More research is needed for new treatments.
The review discusses Male Androgenetic Alopecia (MAA), a common hair loss condition affecting 30-50% of men by age 50, with higher prevalence in Caucasians. MAA can lead to anxiety, depression, and is a risk factor for cardiovascular diseases. The primary treatments are minoxidil and finasteride, which can slow the disease and allow partial hair restoration. If these fail, hair transplantation is an option. The document also mentions a study on Serenoa repens, which showed increased hair counts in men after 12 and 24 weeks of use, suggesting its potential as an alternative treatment. The review concludes with the need for more research to develop new treatment strategies for MAA.
